Design of Mutation‐resistant HIV Protease Inhibitors with the Substrate Envelope Hypothesis
暂无分享,去创建一个
Hong Cao | Bruce Tidor | Michael K Gilson | Visvaldas Kairys | Akbar Ali | Celia A Schiffer | Michael D Altman | Tariq M Rana | Miguel X Fernandes | B. Tidor | M. Gilson | C. Schiffer | T. Rana | M. Altman | V. Kairys | S. Anjum | Akbar Ali | M.N.L. Nalam | H. Cao | G. S. Kiran Kumar Reddy | Sripriya Chellappan | Sripriya Chellappan | Madhavi N L Nalam | G S Kiran Kumar Reddy | Saima Ghafoor Anjum | M. Fernandes | G. S. Kiran Kumar Reddy | Madhavi N. L. Nalam | Saima Ghafoor Anjum
[1] M. Kjeldgaard,et al. O: A Macromolecule Modeling Environment , 1990 .
[2] Ray Luo,et al. Ligand-receptor docking with the Mining Minima optimizer , 2001, J. Comput. Aided Mol. Des..
[3] G. Murshudov,et al. Refinement of macromolecular structures by the maximum-likelihood method. , 1997, Acta crystallographica. Section D, Biological crystallography.
[4] K. N. Trueblood,et al. On the rigid-body motion of molecules in crystals , 1968 .
[5] C. Schiffer,et al. Viability of a Drug-Resistant Human Immunodeficiency Virus Type 1 Protease Variant: Structural Insights for Better Antiviral Therapy , 2003, Journal of Virology.
[6] HIV and AIDS--United States, 1981-2000. , 2001, MMWR. Morbidity and mortality weekly report.
[7] Brian K. Shoichet,et al. ZINC - A Free Database of Commercially Available Compounds for Virtual Screening , 2005, J. Chem. Inf. Model..
[8] Michael K. Gilson,et al. Enhanced docking with the mining minima optimizer: Acceleration and side‐chain flexibility , 2002, J. Comput. Chem..
[9] S. L. Mayo,et al. DREIDING: A generic force field for molecular simulations , 1990 .
[10] Richard J Morris,et al. ARP/wARP's model-building algorithms. I. The main chain. , 2002, Acta crystallographica. Section D, Biological crystallography.
[11] T. Schroer,et al. Subunit organization in cytoplasmic dynein subcomplexes , 2002, Protein science : a publication of the Protein Society.
[12] Celia A Schiffer,et al. Lack of synergy for inhibitors targeting a multi‐drug‐resistant HIV‐1 protease , 2002, Protein science : a publication of the Protein Society.
[13] M. Murcko,et al. Crystal Structure of HIV-1 Protease in Complex with Vx-478, a Potent and Orally Bioavailable Inhibitor of the Enzyme , 1995 .
[14] Charles E. Bugg,et al. Crystallographic and Modeling Methods in Molecular Design , 1990, Springer New York.
[15] J Kuriyan,et al. Rigid protein motion as a model for crystallographic temperature factors. , 1991, Proceedings of the National Academy of Sciences of the United States of America.
[16] Bryan Chan,et al. Human immunodeficiency virus reverse transcriptase and protease sequence database , 2003, Nucleic Acids Res..
[17] K Schulten,et al. VMD: visual molecular dynamics. , 1996, Journal of molecular graphics.
[18] J. Navaza,et al. AMoRe: an automated package for molecular replacement , 1994 .
[19] Irene T Weber,et al. Ultra-high resolution crystal structure of HIV-1 protease mutant reveals two binding sites for clinical inhibitor TMC114. , 2006, Journal of molecular biology.
[20] Z. Otwinowski,et al. Processing of X-ray diffraction data collected in oscillation mode. , 1997, Methods in enzymology.
[21] C. Schiffer,et al. How does a symmetric dimer recognize an asymmetric substrate? A substrate complex of HIV-1 protease. , 2000, Journal of molecular biology.
[22] Collaborative Computational,et al. The CCP4 suite: programs for protein crystallography. , 1994, Acta crystallographica. Section D, Biological crystallography.
[23] Michael K. Gilson,et al. Fast Assignment of Accurate Partial Atomic Charges: An Electronegativity Equalization Method that Accounts for Alternate Resonance Forms , 2003, J. Chem. Inf. Comput. Sci..
[24] Akbar Ali,et al. Discovery of HIV-1 protease inhibitors with picomolar affinities incorporating N-aryl-oxazolidinone-5-carboxamides as novel P2 ligands. , 2006, Journal of medicinal chemistry.
[25] E. Freire,et al. Adaptive inhibitors of the HIV-1 protease. , 2005, Progress in biophysics and molecular biology.
[26] Celia A Schiffer,et al. Combating susceptibility to drug resistance: lessons from HIV-1 protease. , 2004, Chemistry & biology.
[27] Celia A. Schiffer,et al. Structural and Thermodynamic Basis for the Binding of TMC114, a Next-Generation Human Immunodeficiency Virus Type 1 Protease Inhibitor , 2004, Journal of Virology.
[28] Michael K Gilson,et al. Evaluation of the substrate envelope hypothesis for inhibitors of HIV‐1 protease , 2007, Proteins.